15 Mar 2019 by admin in UncategorizedComments Crescendo Biologics wins in “Life Science Innovation” category at the Business Weekly Awards 2019
07 Mar 2019 by admin in UncategorizedComments Syros Reports Fourth Quarter and Full Year 2018 Financial Results and Highlights Multiple Upcoming Clinical Milestones for Its First-in-Class Programs
04 Mar 2019 by admin in UncategorizedComments NextCure and Yale Publish Nature Medicine Paper Detailing Novel Immunomedicine Target Siglec-15
28 Feb 2019 by admin in UncategorizedComments Syros to Report Fourth Quarter and Full Year 2018 Financial Results on Thursday, March 7, 2019
12 Feb 2019 by admin in UncategorizedComments NextCure Announces Formation of Scientific Advisory Board to Guide Development of its Portfolio of Immunomedicines
06 Jan 2019 by admin in UncategorizedComments Syros Announces Strategic Priorities and Expected Milestones
03 Jan 2019 by admin in UncategorizedComments Crescendo Biologics announces Humabody® evaluation in CAR-T by Takeda
05 Dec 2018 by admin in UncategorizedComments Centrexion Therapeutics Announces Completion of Patient Enrollment in Pivotal Phase 3 Clinical Trial of CNTX-4975 for the Treatment of Moderate to Severe Knee Osteoarthritis Pain
